articles about PCV2
Zoetis launches CircoMax® Myco to deliver broader coverage against PCV2
Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.
Zoetis Receives European Commission Marketing Authorization for CircoMax® Myco
First PCV2 and M. hyopneumoniae combination vaccine in the EU for pigs that includes two PCV2 genotypes for broader coverage against continuously evolving Porcine Circovirus.
PRRS: future lines of research
Dr. Nauwynck reviews with us the main gaps in PRRSV research and how he envisions the future of this disease regarding diagnostic technologies and vaccination strategies.
Viral pneumonia in pigs
A discussion of the different micro and macroscopic lesions caused by PRRSV, PCV-2, swine flu virus, and porcine respiratory coronavirus.
What has changed about porcine circovirus epidemiology?
The world of viruses is dynamic. Their epidemiology varies according to our actions. New strains and new serotypes appear. Are we prepared?
20 years of PCV2 - What has changed? - a monograph
It has been 20 years since wasting disease appeared. Are vaccines still effective? Has the disease's epidemiology changed? Should we be concerned about new PCV2 strains or PCV3?
20 years of porcine circovirus type 2: what has changed?
In the years since the PCV-2 vaccine was introduced to solve the enormous problem caused by circovirus, what do you think has changed and how does it affect farms?
PCV-2 genotype update and proposal of a new genotyping methodology
Fecal transplantation and prevention of porcine circovirus associated disease
The gut microbiome provides an alternative tool for control and prevention of diseases.
The use of oral fluids to monitor key pathogens in porcine respiratory disease complex
The microbiome and viral infections
This article relates different microbiome profiles to greater or lesser severity in clinical signs, lesions and viral load in a co-infection with PRRS and PCV2 viruses, opening a window of opportunity.
Effect of vaccination against sub-clinical PCV2 infection in a high-health finishing pig herd
A competitive ELISA differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera
Global molecular genetic analysis of PCV2
The current diagnostic tests are very powerful, allowing us to detect even small changes in the genome of a virus, but what do they tell us?
The impact of intensive vaccination on PCV2 epidemiology
The decrease in PCV2a and PCV2b genotypes over time and the increase in PCV2d in 2012 may be due more to other, unknown, factors than to immunological selection resulting from PCV2a-based vaccination.